kidneycan.org
Oct 23, 2024, 06:59
Laura Esfeller: SWOG S2200 is still enrolling patients
Laura Esfeller, Director of Marketing Services at San Manuel Band of Mission Indians, shared a post on X:
“Don’t forget: SWOG Cancer Research Network S2200 is still enrolling patients! Exciting study for a group of us in kidney cancer who don’t have a lot of clinical trial options: metastatic papillary RCC. The amazing is leading PAPMET2.”
Benjamin Maughan, Medical Oncologist at Johns Hopkins School of Medicine, shared this post adding:
“Lots to learn from this and other ongoing trials in papillary kidney cancer. S1500 and others show us that it’s possible — please consider this trial for all your patients with this disease.”
More posts featuring Laura Esfeller.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 21:47
Nov 21, 2024, 21:40
Nov 21, 2024, 21:36
Nov 21, 2024, 21:27
Nov 21, 2024, 21:23
Nov 21, 2024, 21:17
Nov 21, 2024, 21:07
Nov 21, 2024, 17:57